This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, X.
Right arrow Articles by Gerlich, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, X.
Right arrow Articles by Gerlich, W. H.

 Previous Article  |  Next Article 

J. Virol., Apr 1996, 2277-2285, Vol 70, No. 4
Copyright © 1996, American Society for Microbiology

Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line

X Lu, TM Block and WH Gerlich
Institute of Medical Virology, Justus-Liebig-University, Giessen, Germany.

The human hepatoblastoma cell line HepG2 produces and secretes hepatitis B virus (HBV) after transfection of cloned HBV DNA. Intact virions do not infect these cells, although they attach to the surface of the HepG2 cell through binding sites in the pre-S1 domain. Entry of enveloped virions into the cell often requires proteolytic cleavage of a viral surface protein that is involved in fusion between the cell membrane and the viral envelope. Recently, we observed pre-S- independent, nonspecific binding between hepatitis B surface (HBs) particles and HepG2 cells after treatment of HBs antigen particles with V8 protease, which cleaves next to a putative fusion sequence. Chymotrypsin removed this fusion sequence and did not induce binding. In this study, we postulate that lack of a suitable fusion-activating protease was the reason why the HepG2 cells were not susceptible to HBV. To test this hypothesis, virions were partially purified from the plasma of HBV carriers and treated with either staphylococcal V8 or porcine chymotrypsin protease. Protease-digested virus lost reactivity with pre-S2-specific antibody but remained morphologically intact as determined by electron microscopy. After separation from the proteases, virions were incubated with HepG2 cells at pH 5.5. Cultures inoculated with either intact or chymotrypsin-digested virus did not contain detectable levels of intracellular HBV DNA at any time following infection. However, in cultures inoculated with V8-digested virions, HBV-specific products, including covalently closed circular DNA, viral RNA, and viral pre-S2 antigen, could be detected in a time-dependent manner following infection. Immunofluorescence analysis revealed that 10 to 30% of the infected HepG2 cells produced HBV antigen. Persistent secretion of virus by the infected HepG2 cells lasted at least 14 days and was maintained during several reseeding steps. The results show that V8-digested HBV can productively infect tissue cultures of HepG2 cells. It is suggested that proteolysis-dependent exposure of a fusion domain within the envelope protein of HBV is necessary during natural infection.


This article has been cited by other articles:

  • Lepere-Douard, C., Trotard, M., Le Seyec, J., Gripon, P. (2009). The First Transmembrane Domain of the Hepatitis B Virus Large Envelope Protein Is Crucial for Infectivity. J. Virol. 83: 11819-11829 [Abstract] [Full Text]  
  • Blanchet, M., Sureau, C. (2007). Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues. J. Virol. 81: 5841-5849 [Abstract] [Full Text]  
  • Maenz, C., Chang, S.-F., Iwanski, A., Bruns, M. (2007). Entry of Duck Hepatitis B Virus into Primary Duck Liver and Kidney Cells after Discovery of a Fusogenic Region within the Large Surface Protein. J. Virol. 81: 5014-5023 [Abstract] [Full Text]  
  • Stoeckl, L., Funk, A., Kopitzki, A., Brandenburg, B., Oess, S., Will, H., Sirma, H., Hildt, E. (2006). Identification of a structural motif crucial for infectivity of hepatitis B viruses. Proc. Natl. Acad. Sci. USA 103: 6730-6734 [Abstract] [Full Text]  
  • Chojnacki, J., Anderson, D. A., Grgacic, E. V. L. (2005). A Hydrophobic Domain in the Large Envelope Protein Is Essential for Fusion of Duck Hepatitis B Virus at the Late Endosome. J. Virol. 79: 14945-14955 [Abstract] [Full Text]  
  • Huang, T.-J., Lu, C.-C., Tsai, J.-C., Yao, W.-J., Lu, X., Lai, M.-D., Liu, H.-S., Shiau, A.-L. (2005). Novel Autoregulatory Function of Hepatitis B Virus M Protein on Surface Gene Expression. J. Biol. Chem. 280: 27742-27754 [Abstract] [Full Text]  
  • Grgacic, E. V. L. (2002). Identification of structural determinants of the first transmembrane domain of the small envelope protein of duck hepatitis B virus essential for particle morphogenesis. J. Gen. Virol. 83: 1635-1644 [Abstract] [Full Text]  
  • Cho, E., Park, J., Yoo, O., Kim, K. (2001). Translocation and accumulation of exogeneous hepatitis B virus preS surface proteins in the cell nucleus. J. Cell Sci. 114: 1115-1123 [Abstract]  
  • Grgacic, E. V. L., Schaller, H. (2000). A Metastable Form of the Large Envelope Protein of Duck Hepatitis B Virus: Low-pH Release Results in a Transition to a Hydrophobic, Potentially Fusogenic Conformation. J. Virol. 74: 5116-5122 [Abstract] [Full Text]  
  • Qiao, M., Scougall, C. A., Duszynski, A., Burrell, C. J. (1999). Kinetics of early molecular events in duck hepatitis B virus replication in primary duck hepatocytes. J. Gen. Virol. 80: 2127-2135 [Abstract] [Full Text]  
  • Su, Y.-H., Meegalla, R. L., Chowhan, R., Cubitt, C., Oakes, J. E., Lausch, R. N., Fraser, N. W., Block, T. M. (1999). Human Corneal Cells and Other Fibroblasts Can Stimulate the Appearance of Herpes Simplex Virus from Quiescently Infected PC12 Cells. J. Virol. 73: 4171-4180 [Abstract] [Full Text]  
  • Lu, X., Mehta, A., Dadmarz, M., Dwek, R., Blumberg, B. S., Block, T. M. (1997). Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proc. Natl. Acad. Sci. USA 94: 2380-2385 [Abstract] [Full Text]  
  • Mehta, A., Lu, X., Block, T. M., Blumberg, B. S., Dwek, R. A. (1997). Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA 94: 1822-1827 [Abstract] [Full Text]  
  • Lambert, C., Prange, R. (2001). Dual Topology of the Hepatitis B Virus Large Envelope Protein. DETERMINANTS INFLUENCING POST-TRANSLATIONAL PRE-S TRANSLOCATION. J. Biol. Chem. 276: 22265-22272 [Abstract] [Full Text]